cas 1256667-56-7|| where to buy (3R)-1-(Oxetan-3-yl)pyrrolidin-3-amine

Nombre del producto:(3R)-1-(Oxetan-3-yl)pyrrolidin-3-amine

IUPAC Name:(3R)-1-(oxetan-3-yl)pyrrolidin-3-amine

Unidad de embalaje	Stock disponible	Precio($)
CM284085-100mg	in stock	ŽǸƴ
CM284085-250mg	in stock	ǎƚř
CM284085-1g	in stock	ħŌƚ

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1256667-56-7 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :1256667-56-7; Fórmula molecular:C7H14N2O; Punto de fusión:-; Código de sonrisas:N[C@H]1CN(C2COC2)CC1; Densidad:

: Número de catálogo:CM284085; Peso molecular:142.2; Punto de ebullición:; Nº Mdl:; Almacenamiento:Keep in dark place, inert atmosphere, store at 2-8°C.

: Pyrrolidines; Pyrrolidine, also known as tetrahydropyrrole, is a saturated five-membered heterocyclic ring, which is miscible with water. Pyrrolidine exists in many alkaloids and drug molecules, such as kappa opioids, antagonists of dopamine D4 receptors, and HIV reverse transcriptase inhibitors.

: Oxetanes; Oxygen heterocycles are one of the most common heterocycles in drugs and natural products. Oxetene has high polarity and is also a good acceptor for hydrogen bond, which contributes to the metabolism and chemical stability of its host molecules. When substituted for commonly used functional groups such as gem dimethyl or carbonyl, oxetane units can induce profound changes in water solubility, lipophilicity, metabolic stability and conformational preference. Four of the FDA-approved drugs contain oxetenes: Orlistat, Paclitaxel, and two of its derivatives, Docetaxel and Cabazitaxel. Currently, oxetane-containing building blocks are flourishing in medicinal chemistry and drug discovery.